Filter by:
2015 was marked by record cocaine seizures - close on 11 tonnes - on French territory.
The public authorities and health and prevention activists are paying particular attention to the use of psychoactive substances in adolescents.
The data presented in this issue of Tendances have been collected as part of the RECAP survey (Recueil commun sur les addictions et les prises en charges or Common data collection on addictions and treatments) carried out in 2005 at a national level for the first time.
An online survey among users of New Psychoactive Substances (NPS) was conducted in France, the Netherlands, Poland and the Czech Republic in 2014, in the context of the I-TREND project, supported by the European Commission.
This issue of Tendances includes four articles. How many opiate users are there on high dosage buprenorphine (HDB)? Impact of substitution treatments: assessment of the last ten years. HDB misuse. Non-substitutive uses of high dosage buprenorphine in France.
The Covid-19 pandemic is the origin of a health crisis that has led to more than 848 000 deaths worldwide in seven months, including more than 30 000 in France.
This issue offers, for the period July 2002 to the end of September 2003, an update on the observations made by the socio-health network.
Nearly twenty years after they were first launched in France (1995), opioid substitution treatments (OSTs) remain a cornerstone of the country’s harm reduction policy.
Within the framework of the government's action plan against illicit drugs, tobacco and alcohol (2004-2008), a prevention programme against cannabis use has been up.
In 2006 the French health authorities are setting up a strategy for the widespread dissemination of early detection and short-term interventions (RPIB in French) on alcohol to general practitioners.